Trial intelligence / Profile preview

Duvelisib in mild asthmatic subjects undergoing allergen challenge

NCT01653756Phase 2Completed

Sponsor
Secura Bio
Start
Jul 2012
Primary completion
Aug 2014
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of duvelisib in asthma, sponsored by Secura Bio. Started Jul 2012; status: completed.

02

Drugs

duvelisib
03

Conditions

asthma

Beyond the preview

Go deeper on NCT01653756.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01653756.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call